New study challenges role of rectal exam in prostate cancer screening

A study by the Comprehensive Cancer Center Vienna of MedUni Vienna and Vienna General Hospital has taken a closer look at the effectiveness of common examination methods for the early detection of prostate cancer.

Teva, Sanofi conclude collaboration deal for anti TL1A therapy

Share this article TEV ‘574 is under assessment in Phase IIb clinical studies to treat ulcerative colitis and Crohn’s disease. Credit: sdecorated / Shutterstock.com. Teva

December 1, 2023

Off-the-shelf and on the decline: Adicet Bio’s shares halved after PhI look at cell therapy

Adicet Bio’s stock price was halved on Tuesday morning as investors tanked the biotech’s shares $ACET following a look at Phase I data on its

June 28, 2023

Consumer and labor groups urge FTC to block Catalent sale to Novo Holdings

A coalition of unions, consumer groups and public interest organizations urged the Federal Trade Commission to challenge a $16.5 billion deal in which Novo Nordisk’s parent

October 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.